期刊文献+

定量组织速度成像在肥厚型梗阻性心肌病化学消融术前后的应用 被引量:3

Application of quantitative tissue velocity imaging in percutaneous transluminal septal myocardial ablation of hypertrophic obstructive cardiomyopathy
原文传递
导出
摘要 目的应用定量组织速度成像(QTVI)评价肥厚型梗阻性心肌病化学消融术前及术后左心室局部收缩功能,并探讨前间隔基底段(靶组织)收缩速度与左室流出道压差关系。方法23例肥厚型梗阻性心肌病患者于化学消融术前及术后3d,超声心动图测量左室流出道压差;应用QTVI技术在心尖左室长轴观及心尖四腔观测量前间隔、后壁、后间隔和侧壁基底段与中间段的纵向收缩期峰值速度(Vp),在胸骨旁左心室长轴观测量前间隔及后壁基底段与中间段的横向Vp。结果肥厚型梗阻性心肌病患者前间隔基底段的纵向及横向Vp术后[分别为(3.25±0.63)cm/s、(2.93±0.47)cm/s]较术前[分别为(5.73±0.96)cm/s、(4.87±0.69)cm/s]减低(P〈0.05)。肥厚型梗阻性心肌病患者左室流出道压差术后[(23.7±7.8)mmHg]较术前[(78.3±16.5)mmHg]下降(P〈0.01),左室流出道压差下降与前间隔基底段Vp下降显著相关(r=0.95,P〈0.01)。结论肥厚型梗阻性心肌病化学消融术后前间隔基底段收缩功能下降,左室流出道压差下降与前间隔基底段收缩功能下降有关。  Objective By quantitative tissue velocity imaging(QTVI),to evaluate regional left ventricular(LV) contractile function before and after percutaneous transluminal septal myocardial ablation (PTSMA) in patients with hypertrophic obstructive cardiomyopathy (HOCM),and to investigate correlation between the peak systolic velocity(Vp) at the base segments of anterior interventricular septum with LV outflow-trace gradient(LVOTG).Methods Before and 3 days after PTSMA in 23 patients with HOCM,LVOTG were measured,Vp at the base and middle segments of anteroseptal,posterior,posterseptal and lateral along LV apical long-axis view and apical four-chamber view were measured by QTVI,Vp at the base and middle segments of anteroseptal,posterior along LV parasternal the long-axis view were measured by QTVI.Results Three days after PTSMA,Vp at the base segments of anteroseptal decreased significantly from (5.73±0.96)cm/s to (3.25±0.63)cm/s along LV apical long-axis view,from (4.87±0.69)cm/s to (2.93±0.47)cm/s along LV parasternal the long-axis view (P〈0.05).LVOTG reduced significantly from (78.3±16.5)mm Hg to (23.7±7.8)mm Hg(P〈0.01).LVOTG correlated positively to Vp at the base segments of anteroseptal (r=0.95,P〈0.01).Conclusions After PTSMA in patients with HOCM,Vp at the base segments of anteroseptal significantly decreased and LVOTG significantly reduced,LVOTG had a good linear correlation to Vp at the base segments of anteroseptal.
出处 《中华超声影像学杂志》 CSCD 2007年第10期829-831,共3页 Chinese Journal of Ultrasonography
关键词 超声心动描记术 心肌病 肥厚性 导管消融术 组织速度成像 Echocardiography Cardiomyopathy,hypertrophic Catheter ablation Tissue velocity imaging
  • 相关文献

参考文献6

  • 1Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet, 1995,346 : 211-214.
  • 2Seggewiss H, Faber L, Gleichmann U. Percutaneous transluminal septal myocardial ablation of hypertrophic obstructive eardiomyopathy. Thorae Cardiovase Surg, 1999,47 : 94-100.
  • 3Lakkis NM, Nagueh SF, Kleiman NS, et al. Eehoeardiography-guided ethanol septal reduetion for hypertrophie obstruetive eardiomyopathy. Cireulation, 1998,98: 1750-1755.
  • 4张明,李占全,金元哲,刘莹,袁龙,关汝明,张薇薇,徐桂萍,侯平,石蕴琦.经皮经腔间隔心肌化学消融术治疗肥厚型梗阻性心肌病两年疗效观察[J].中华心血管病杂志,2003,31(2):122-125. 被引量:18
  • 5Cardim N, Morais H, Candido A, et al. Tissue Doppler imaging: clinical topics for the new millennium. Rev Port Cardiol, 2000, 19: 449-458.
  • 6傅国胜,徐耕,游向东,鲍晓峰,马骥,聂文成,陈样新,程刚,潘晓宏,翁少翔,单江.肥厚型梗阻性心肌病无水酒精消融术靶血管选择方法的探讨[J].中华心血管病杂志,2004,32(5):419-421. 被引量:6

二级参考文献14

  • 1朱晓东,吴洪斌,胡盛寿,胡宝琏.肥厚性梗阻型心肌病的外科治疗[J].中华胸心血管外科杂志,1997,13(2):73-75. 被引量:5
  • 2辽宁省化学消融术协作组.经皮腔内室间隔化学消融术治疗肥厚型梗阻性心肌病近期疗效观察[J].中华心血管病杂志,2001,29(1):8-8.
  • 3Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.Lancet,1995,346: 211-214.
  • 4Seggewiss H, Faber L, Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.Thorac Cardiovasc Surg, 1999,47: 94-100.
  • 5Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation,1998, 98: 2415-2421.
  • 6Schulte HD, Borisov K, Gams E, et al. Management of symptomatic hypertrophic obstructive cardiomyopathy--long-term results after surgical therapy. Thorac Cardiovasc Surg, 1999, 47: 213-218.
  • 7Feigenbaum H. Coronary artery disease: detection of ischemic muscle. In: Feigenbaum H, ed. Echocardiography. 4th ed. Philadelphia: Lea & Febiger, 1985. 462-467.
  • 8Hubert Seggewiss MD. Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy[J] 2001,Current Cardiology Reports(2):160~166
  • 9赵林阳,王大伟,杨平,魏大愚,周方钧,杨海山,郭喜田.经导管化学消蚀心肌治疗肥厚性梗阻型心肌病(附一例报告)[J].中华心血管病杂志,1998,26(1):70-71. 被引量:54
  • 10李占全,张明,关汝明,金元哲,张薇薇,楚世文,王效刚,孙玲,程玉海,王丽君,攸翔,王伟.经皮经冠状动脉室间隔化学消融术治疗梗阻性肥厚型心肌病的近期疗效观察[J].中华心血管病杂志,2001,29(1):8-11. 被引量:40

共引文献22

同被引文献20

  • 1傅国胜,徐耕,游向东,鲍晓峰,马骥,聂文成,陈样新,程刚,潘晓宏,翁少翔,单江.肥厚型梗阻性心肌病无水酒精消融术靶血管选择方法的探讨[J].中华心血管病杂志,2004,32(5):419-421. 被引量:6
  • 2Lakkis NM,Naguch SF,Kleiman NS,et al.Echocardiographyguided ethanol septal reduction for hypertrophic obstructive cardiomyopathy.Circulation,1998,98:1750-1755.
  • 3Zhang Y,Chan AK,Yu CM,et al.Left ventricular systolic asynchrony after acute myocardial infarction in patients with narrow QRS complexes.Am Heart J,2005,149:497-503.
  • 4Mollema SA,Liem SS,Suffoletto MS,et al.Left ventricular dyssynchrony acuteIy after myocardial infarction predicts left ventricular remodeling.J Am Coll Cardiol,2007,50:1532-1540.
  • 5Shin SH,Hung CL,Uno H,et al.Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction.heart failure,or both.Circulation,2010,121:1096-1103.
  • 6Faber L, Seggewiss H, Gleichmann U. Percutaneous translumi- nal septal myocardial ablation in hypertrophic obstructive eardio- myopathy. Results with respect to intraprocedural myocardial contrast echocardiography. Circulation, 1998, 98 ( 22 ) : 2415- 2421.
  • 7van der Lee C, ten Cate FJ, Geleijnse ML, et al. Percutaneous versus surgical treatment for patients with hypertrophic obstruc- tive cardiomyopathy and enlarged anterior mitral valve leaflets. Circulation, 2005,112(4) :482-488.
  • 8Bonow RO, Carabello B, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart dis- ease: A report of the American Coliege of Cardiology/American Heart Association Task Force Oil Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coil Cardiol, 2006,48 (3) : el-el48.
  • 9Koffiard M], Ten Care FJ, van der Lee C, et al. Hypertrophiccardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coil Cardiol, 2003, 41 (6):987- 993.
  • 10Henein MY, O'sullivan CA, Ramzy IS, et al. Electromechanical left ventricular behavior after nonsurgical septal reduction in pa- tients with hypertrophic obstructive cardiomyopathy. J Am Coil Cardiol, 1999,34(4) : 1117-1122.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部